Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been detected in some patients with AQP4-IgG seronegative NMO as well as with recurrent optic neuritis, longitudinally extensive transverse myelitis, MS and SLE [9]. This evidence concerns the gene AQP4 and myeloid sarcoma.